(MedPage Today) — At the San Antonio Breast Cancer Symposium, investigators presented results from HER2CLIMB-05, a registrational trial evaluating the addition of tucatinib (Tukysa) to trastuzumab (Herceptin) and pertuzumab (Perjeta) maintenance…
In a race against time, Telangana targets 8-minute emergency response to cut road accident deaths
In a race against time, Telangana targets 8-minute emergency response to cut road accident deaths Source: www.thehindu.com Medical Disclaimer: This...






